Hapten Carrier Conjugation Kits

Recombinant protein fragment of Human ASTN1&nbspwith&nbspN-terminal His 6 ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag.&nbsp &nbsp&nbsp Application Blocking agent and positive assay control using

Recombinant protein fragment of Human AURKC with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

PrEST Antigen C1orf21 chromosome 1 open reading frame 21, 10

PrEST Antigen CCDC137 coiled-coil domain containing 137, 100

PrEST Antigen CDADC1 cytidine and dCMP deaminase domain cont

Recombinant protein fragment of Human CLDN10 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human CLDN25 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

PrEST Antigen CPT2 carnitine palmitoyltransferase 2, 100ul U

Recombinant protein fragment of Human CTTN with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human DCTN1 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

N-terminal His 6 ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) Application Suitable as a blocking agent and positive assay control using corresponding antibodies. Linkage Corresponding Antibodies HPA071875 Physical form

Recombinant protein fragment of Human DCTN3 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.